Quant Biomarkers
Development and application of human biomarker panels and biological age metrics
Data-driven financial and biotechnology company, specialized in quantitative assessment of human biomarkers, development of biomarker panels and biological age metrics, their application for investment de-risking, insurance and hedging objectives, development of structured financial products and analytics linked to human biomarkers and biological age.
The main goal of the company is to introduce biomarker-driven Longevity risks mitigation for a broad group of financial and healthcare-related entities. Founded in November 2021, with headquarters in Basel, Switzerland and branches in the United Kingdom, Germany and Ukraine.
Visit website: https://www.quant-biomarkers.com/
See also: Deep Knowledge Group - Venture capital fund that invests in life sciences, cancer research, age-related diseases and regenerative medicine.
Details last updated 14-Dec-2021
People at Quant Biomarkers
Quant Biomarkers News
Quant Biomarkers established to develop sophisticated analytical products
Quant Biomarkers - 10-Dec-2021
DKG subsidiary to introduce biomarker-driven Longevity risk mitigation and intervention support
Read more...